2株无抗肿瘤活性放线菌野生株的抗生素抗性突变株及其抗肿瘤活性筛选

以2株放线菌无活性野生株M15(海洋)和M13(陆地)为原始菌,利用核糖体工程抗性筛选技术,通过对M15的链霉素、新霉素、利福平、庆大霉素抗性筛选,得到抗性突变株共63株,经对M13的链霉素抗性筛选,得到链霉素抗性突变株18株。其中,6株M15突变株在活性测试中示有抗肿瘤活性,100μg/mL样品对K562细胞的抑制率大于30%,活性最强的1株新霉素8μg/mL抗性突变株CTM154-8N抑制率高达93.3%,而从M13突变株中没有发现活性突变株。     

凋亡细胞的吞噬清除

吞噬清除是后生动物大多数凋亡细胞的共同命运。凋亡细胞如果不被有效及时清除,它们就会发生次级的细胞坏死,细胞核膜和细胞核裂解,细胞解体,释放出有毒内容物,导致严重炎症和狼疮样自身免疫疾病的发生。据估计人体内每天有上亿个细胞凋亡而死,但用组化方法只能检测到极少数凋亡细胞,说明人体对凋亡细胞清除效率很高。新近,对凋亡细胞吞噬清除分子机制的研究取得长足进展。本文主要就吞噬信号及其识别、传导和凋亡细胞的吞噬作简要概述。     

星座美洲海鞘次级代谢产物的研究

从采自青岛近海的星座美洲海鞘(Amaroucium constellatum)70%乙醇提取物中分离得到9个次级代谢产物.经波谱(MS、NMR)分析和文献比对,确定了它们的化学结构分别为尿嘧啶(1)、胆甾醇(2)、十九碳甘油醚(3)、胸腺嘧啶(4)、反-4-对羟基苯基-3-丁烯-2-酮(5)、反-4-苯基-3-丁烯-2-酮(6)、对胺基苯乙酸(7)、胸腺嘧啶脱氧核苷(8)和N-甲基尿嘧啶核苷(9).其中,化合物2～3,5～7,9均为首次从该海鞘中分离得到.     

拮抗香蕉枯萎病菌海洋细菌的筛选和鉴定

从93份中国南部海域近海海泥样品中分离出1800多株海洋细菌,以对峙培养法,测定海洋细菌对香蕉枯萎菌的拮抗作用,再以琼脂划线培养法(agar streak)测定菌株的抑菌活性,结果表明:约55.6%的菌株对香蕉枯萎菌有一定的拮抗作用,其中58株菌株抑制香蕉枯萎菌生长所形成的抑菌带宽度大于10.0mm,抑菌作用较好,复筛后其中13个菌株形成的抑菌带宽在15.0mm以上。经反复转接和对峙培养,筛选出拮抗效果好、抑菌活性稳定的菌株TC-1,初步鉴定为芽孢杆菌属的细菌,TC-1对14种病原微生物都有较好的抑菌效果。     

强壮前沟藻(Amphidinium carterae Hulburt)毒素的溶血活性研究

以实验室单种培养的强壮前沟藻为对象,研究了强壮前沟藻毒素的来源,分析了藻毒素浓度与溶血活性的相关性,研究了理化因子对藻毒素溶血活性的影响。结果表明,溶血活性随着强壮前沟藻细胞的增殖呈上升的趋势,细胞内容物和细胞碎片的溶血活性显著高于去藻过滤液,强壮前沟藻毒素主要来源于衰亡期的细胞内容物和细胞碎片,并存在浓度相关的溶血性。强壮前沟藻毒素的溶血活性不存在光敏感性。随着pH的上升,毒素溶血活性呈降低趋势。Ca2+、Mn2+、Cu2+抑制了强壮前沟藻毒素溶血活性,而Co2+、Zn2+显著的增强了溶血活性,Mg2+对其溶血活性的影响不显著。EDTA对强壮前沟藻毒素的溶血活性有显著的促进作用。     

瘤状软骨凹顶藻化学成分研究

采用硅胶柱色谱以及Sephadex LH-20凝胶色谱手段,对海洋红藻瘤状软骨凹顶藻(Chondrophycus papillous Garbary et Harper)进行化学成分研究,分离得到5个化合物.通过MS、NMR等方法对得到的化合物进行结构确证,分别鉴定为邻苯二甲酸二丁酯(Ⅰ),邻苯二甲酸二异辛酯(Ⅱ),胆甾醇(Ⅲ),植醇(Ⅳ)和4-羟基苯甲醛(Ⅴ).所有化合物均为首次从该种海藻中分离得到.通过MTT法对得到的单体化合物进行细胞毒活性筛选,结果显示所有化合物在10 mg/L浓度下均无明显活性.     

壳聚糖硫酸酯金属配合物的抗氧化活性

以吩嗪硫酸甲酯-NADH为超氧阴离子自由基(O_2~(·-))产生、检测体系和EDTANa_2-Fe(Ⅱ)-H_2O_2为羟自由基(~·OH)产生、检测体系,对壳聚糖硫酸酯铜、锌配合物和不同分子质量壳聚糖进行了抗O_2~(·-)和~·OH自由基的活性研究.结果表明,壳聚糖硫酸酯金属配合物对于O_2~(·-)自由基的清除能力明显高于壳聚糖,在质量浓度为0.025 g/L时,壳聚糖硫酸酯铜配合物对O_2~(·-)自由基的清除能力达到94.18%,壳聚糖硫酸酯锌配合物达到93.19%;壳聚糖硫酸酯铜、锌配合物对~·OH自由基的清除能力(67.39%、60.46%)低于相同分子质量的壳聚糖(88.06%),而高于高分子质量壳聚糖761 ku(18.71%);壳聚糖分子质量大小对O_2~(·-)和~·OH自由基的清除能力有较大影响,质量浓度为1.6 g/L壳聚糖分子质量为20 ku时,对O_2~(·-)清除率达54.69%,而分子质量在761 ku时,对O_2~(·-)清除率仅为35.50%;各样品对O_2~(·-)和~·OH自由基的清除能力均随着质量浓度的增加而上升,壳聚糖硫酸酯铜、锌配合物在相当低的浓度下(0.025 g/L)就可以达到明显清除O_2~(·-)自由基的效果(≥90%).     

The selection of alkaline protease-producing yeasts fi＇om marine environments and evaluation of their bioactive peptide production

A total of 400 yeast strains from seawater, sediments, saltern mud, marine fish guts, and marine algae were obtained. The protease activity of the yeast cultures was estimated, after which four strains (HN3.11, N11b, YF04C and HN4.9) capable of secreting extracellular alkaline protease were isolated. The isolated strains were identified as Aureobasidium pullulans, Yarrowia lipolytica, Issatchenkia orientalis and Cryptococcus cf. aureus. The optimal pH of the protease activity produced by strains HN3.11, YF04C, and HN4.9 was 9.0, while that of the protease produced by strain N11b was 10.0. The optimal temperature for protease activity was 45°C for strains HN3.11, N11b, and YF04C, and 50°C for strain HN4.9. After digestion of shrimp (Penaeus vannamei) protein and spirulina (Arthospira platensis) protein with the four crude alkaline proteases, the filtrate from spirulina (Arthrospira platensis) powder digested by the crude alkaline protease of strain HN3.11 was found to have the highest antioxidant activity (61.4%) and the highest angiotensin I converting enzyme (ACE)-inhibitory activities (68.4%). The other filtrates had much lower antioxidant activity and ACE-inhibitory activities.     

Antiangiogenic activity of low-temperature lysozyme from a marine bacterium <Emphasis Type="Italic">in vivo</Emphasis> and <Emphasis Type="Italic">in vitro</Emphasis>

We extracted marine low-temperature lysozyme (MLTL), a novel lysozyme, from a marine microorganism through fermentation. Our previous study suggested that a low molecular weight (16 kDa) may exert anti-tumor activity through antiangiogenesis. In this study, we extracted a high weight (39 kDa) and investigated its antiangiogenic activity in vivo and in vitro. Using zebrafish embryos as an in vivo study model, we found that treatment with MLTL significantly inhibited the growth of subintestinal vessels (SIVs) in a dose-dependent manner and that 400 μg/ml MLTL was sufficient to block the growth of SIVs. An in vitro study conducted using human umbilical vein endothelial cells (HUVECs) revealed that MLTL suppressed the proliferation, migration and tube formation of HUVECs in a dose-dependent manner. Interestingly, assays by flow cytometry and DNA electrophoresis indicated that MLTL was able to induce apoptosis of HUVECs. Moreover, further study demonstrated that the disruption of intracellular Ca²⁺ homeostasis may play an important role in MLTL induced apoptosis of HUVECs. Taken together, the results of this study demonstrate for the first time that MLTL inhibits angiogenesis through its pleiotropic effects on vascular endothelial cells and induces apoptosis through regulation of cellular Ca²⁺ levels. The results of this study also revealed a possible mechanism underlying the antiangiogenic effect of MLTL and suggested that MLTL may be a promising new antiangiogenic agent for use in cancer therapy.     

马氏珠母贝免疫活性肽的纯化与鉴定

为制备马氏珠母贝免疫活性肽,以马氏珠母贝全脏器为原料,利用体外模拟消化的方法对其进行酶解,然后通过超滤系统收集分子量小于3 ku的酶解液。采用细胞培养方法,以体外免疫活性为指标,利用Sephadex G-25凝胶柱层析、Capto Q强阴离子交换色谱等对马氏珠母贝酶解液进行分离纯化与筛选,获得2个具有免疫活性的肽段,利用电喷雾静电场离子阱串联质谱分别对2个活性肽序列进行测定。结果表明:一个肽的相对分子质量为245.0,肽序列为Ala-Arg/Pro-Met;另一个别肽的相对分子质量为274.0,肽序列为Val-Arg。在浓度0.3 mg/m L时,2种肽能显著促进脾淋巴细胞的增殖与提高巨噬细胞的吞噬能力,表明这2种肽均具有较好的免疫活性。